{
    "id": "35ceeae7-4f25-4d5a-e063-6394a90a8ff7",
    "indications": "nystatin oral suspension indicated treatment candidiasis oral cavity .",
    "contraindications": "infants : 2 ml ( 200,000 units ) four times daily ( infants young children , dropper place one-half dose side mouth avoid feeding 5 10 minutes ) . note : limited premature low birth weight infants indicate 1 ml four times daily effective . children adults : 4 6 ml ( 400,000 600,000 units ) four times daily ( one-half dose side mouth ) . preparation retained mouth long possible swallowing . continue treatment least 48 hours perioral symptoms disappeared cultures demonstrate eradication candida albicans .",
    "warningsAndPrecautions": "nystatin oral suspension usp , 100,000 usp nystatin units per ml , available cherry flavored , light creamy yellow , ready-to-use suspension , supplied following oral forms : ndc 17856-1045-01 nystatin oral susp 100,000 units/1ml - 5 ml cup 72 ct ud ndc 17856-1045-02 nystatin oral susp 100,000 units/1ml - 5 ml cup 1ct ud ndc 17856-1045-03 nystatin oral susp 100,000 units/1ml - 5 ml syringe 48 ct ud ndc 17856-1045-04 nystatin oral susp 100,000 units/1ml - 5 ml syringe 1ct ud ndc 17856-1045-05 nystatin oral susp 100,000 units/1ml - 5 ml enfit syringe 48 ct ud ndc 17856-1045-06 nystatin oral susp 100,000 units/1ml - 5 ml enfit syringe 1 ct ud ndc 17856-1045-07 nystatin oral susp 100,000 units/ml - 1 ml enfit syringe 120 ct ud ndc 17856-1045-08 nystatin oral susp 100,000 units/ml - 1 ml enfit syringe 1ct ud ndc 17856-1045-09 nystatin oral susp 100,000 units/1ml - 5 ml enfit syringe 1ct ud overwrap",
    "adverseReactions": "preparation contraindicated patients history hypersensitivity components .",
    "ingredients": [
        {
            "name": "ALCOHOL",
            "code": "3K9958V90M"
        },
        {
            "name": "ANHYDROUS CITRIC ACID",
            "code": "XF417D3PSL"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        },
        {
            "name": "FD&C RED NO. 40",
            "code": "WZB9127XOA"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX"
        },
        {
            "name": "METHYLPARABEN",
            "code": "A2I8C7HI9T"
        },
        {
            "name": "POTASSIUM PHOSPHATE, DIBASIC",
            "code": "CI71S98N1Z"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "PROPYLPARABEN",
            "code": "Z8IX2SC1OH"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "SUCROSE",
            "code": "C151H8M554"
        },
        {
            "name": "MAGNESIUM ALUMINUM SILICATE",
            "code": "6M3P64V0NC"
        },
        {
            "name": "NYSTATIN",
            "code": "BDF1O1C72E"
        }
    ],
    "organization": "ATLANTIC BIOLOGICALS CORP.",
    "name": "Nystatin",
    "effectiveTime": "20250523",
    "indications_original": "Nystatin Oral Suspension is indicated for the treatment of candidiasis in the oral cavity.",
    "contraindications_original": "INFANTS: 2 mL (200,000 units) four times daily (in infants and young children, use dropper to place one-half of dose in each side of mouth and avoid feeding for 5 to 10 minutes).\n                  NOTE: Limited clinical studies in premature and low birth weight infants indicate that 1 mL four times daily is effective.\n                  CHILDREN AND ADULTS: 4 to 6 mL (400,000 to 600,000 units) four times daily (one-half of dose in each side of mouth). The preparation should be retained in the mouth as long as possible before swallowing.\n                  Continue treatment for at least 48 hours after perioral symptoms have disappeared and cultures demonstrate eradication of\n \n  Candida albicans.",
    "warningsAndPrecautions_original": "Nystatin Oral Suspension USP, 100,000 USP Nystatin Units per mL, is available in a cherry flavored, light creamy yellow, ready-to-use suspension, supplied in the following oral dosage forms:\n                  \n                  NDC 17856-1045-01 NYSTATIN ORAL SUSP 100,000 UNITS/1ML - 5 ML CUP 72 ct UD \n    NDC 17856-1045-02 NYSTATIN ORAL SUSP 100,000 UNITS/1ML - 5 ML CUP 1ct UD \n    NDC 17856-1045-03 NYSTATIN ORAL SUSP 100,000 UNITS/1ML - 5 ML SYRINGE 48 ct UD \n    NDC 17856-1045-04 NYSTATIN ORAL SUSP 100,000 UNITS/1ML - 5 ML SYRINGE 1ct UD \n    NDC 17856-1045-05 NYSTATIN ORAL SUSP 100,000 UNITS/1ML - 5 ML ENFIT SYRINGE 48 ct UD \n    NDC 17856-1045-06 NYSTATIN ORAL SUSP 100,000 UNITS/1ML - 5 ML ENFIT SYRINGE 1 ct UD \n    NDC 17856-1045-07 NYSTATIN ORAL SUSP 100,000 UNITS/ML - 1 ML ENFIT SYRINGE 120 ct UD \n    NDC 17856-1045-08 NYSTATIN ORAL SUSP 100,000 UNITS/ML - 1 ML ENFIT SYRINGE 1ct UD \n    NDC 17856-1045-09 NYSTATIN ORAL SUSP 100,000 UNITS/1ML - 5 ML ENFIT SYRINGE 1ct UD OVERWRAP",
    "adverseReactions_original": "The preparation is contraindicated in patients with a history of hypersensitivity to any of its components."
}